When does a project also need review by the Institutional Research Safety Committee (IRSC)?
The IRSC reviews projects that involve hazardous chemicals, recombinant DNA, human etiologic agents classified as BL2 or higher, tissues or blood that are classified as BL3, and human gene therapy. IRSC forms submitted with HSC applications are screened to determine need for IRSC review. Further information is available from the Office of Compliance at 913-588-5492.